Single Cell Genomics Market Assessment

Abstract

Single cell genomics (SCG) is a fast growing, emerging approach in which genomic technologies (i.e., that assess nucleic acids such as DNA or RNA) are applied at the level of single cells, rather than at the level of an entire cell population. The third edition of this report reviews the market size, segmentation, growth and trends of the SCG market. We assess the SCG market across 7 segments and 33 subsegments: customer (e.g., academia, biopharma, applied markets, clinical), workflow step (e.g., cell isolation, sample preparation, genomic analysis), analytical technology (e.g., PCR, qPCR, microarray, next-generation-sequencing, other), field-of-study (e.g., oncology, basic cell biology, stem cell biology, microbiology, neurology, immunology, other), application (e.g., genomic variation, subpopulation characterization, circulating tumor cells, cell differentiation / reprograming, method, other), product type (e.g., instruments, reagents) and geography (e.g., U.S., Europe, Japan, China, Asia-Pacific, ROW). For each of these segments, we provide an estimated market size and growth from 2013 to 2021, as well as key growth drivers and moderators. Special analysis conducted in this report includes the categorization of ~1,400 SCG peer-reviewed publications from 2010 to Feb 2017.